The plasma levels of CST and BCKDK in patients with sepsis

Engel, 2007, Epidemiology of sepsis in Germany: results from a national prospective multicenter study, Intensive Care Med., 33, 606, 10.1007/s00134-006-0517-7 Brun-Buisson, 1995, Incidence, risk-factors, and outcome of severe sepsis and septic shock in adults – a multicenter prospectivestudy in intensive-care units, JAMA, 274, 968, 10.1001/jama.1995.03530120060042 Martin, 2003, The epidemiology of sepsis in the United States from 1979 through 2000, N. Engl. J. Med., 348, 1546, 10.1056/NEJMoa022139 Suberviola, 2012, Prognostic value of procalcitonin, C-reactive protein and leukocytes in septic shock, Med. Intensiva, 36, 177, 10.1016/j.medin.2011.09.008 Assicot, 1993, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet, 341, 515, 10.1016/0140-6736(93)90277-N Agency for Healthcare Research and Quality. Effctive Health Care Program. EPC Project.Project Title: Procalcitonin for diagnosis and Management of Sepsis. Research protocol, 2011. Available at: http://www.effctivehealthcare.ahrq.gov. Chan, 2011, Early diagnosis of sepsis using serum biomarkers, Expert Rev. Mol. Diagn., 11, 487, 10.1586/erm.11.26 Schuetz, 2009, Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections–hope for hype?, Swiss Med. Wkly., 139, 318 Rogers, 2014, Metabolomic derangements are associated with mortality in critically ill adult patients, PLoS One, 9, e87538, 10.1371/journal.pone.0087538 Knerr, 2012, Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects, J. Inherit. Metab. Dis., 35, 29, 10.1007/s10545-010-9269-1 de Lecea, 1996, A cortical neuropeptide with neuronal depressant and sleep-modulating properties, Nature, 381, 242, 10.1038/381242a0 Spier, 2000, Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions, Brain Res. Brain Res. Rev., 33, 228, 10.1016/S0165-0173(00)00031-X Cassoni, 2002, Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin, J. Endocrinol. Invest., 25, 362, 10.1007/BF03344019 Gonzalez-Rey, 2006, Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease, Proc. Natl. Acad. Sci. U. S. A., 103, 4228, 10.1073/pnas.0508997103 Broglio, 2007, Brain-gut communication: cortistatin, somatostatin and ghrelin, Trends Endocrinol. Metab., 18, 246, 10.1016/j.tem.2007.06.004 Gahete, 2008, Are somatostatin and cortistatin two siblings in regulating endocrine secretions? In vitro work ahead, Mol. Cell. Endocrinol., 286, 128, 10.1016/j.mce.2007.11.013 Gonzalez-Rey, 2006, Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia, J. Exp. Med., 203, 563, 10.1084/jem.20052017 Zhang, 2015, Cortistatin protects myocardium from endoplasmic reticulum stress induced apoptosis during sepsis, Mol. Cell. Endocrinol., 406, 40, 10.1016/j.mce.2015.02.016 Zhang, 2015, Cortistatin inhibits NLRP3 inflammasome activation of cardiac fibroblasts during sepsis, J. Card. Fail., 21, 426, 10.1016/j.cardfail.2015.01.002 Levy, 2003, SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference, Intensive Care Med., 31, 530, 10.1007/s00134-003-1662-x Mehanic, 2013, The importance of serum procalcitonin in diagnosis and treatment of serious bacterial infections and sepsis, Mater. Sociomed., 25, 277, 10.5455/msm.2013.25.277-281 Li, 2015, Canadian B cells in MS Team. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy, Sci. Transl. Med., 7, 310ra166, 10.1126/scitranslmed.aab4176 Broglio, 2008, Endocrine actions of cortistatin: in vivo studies, Mol. Cell. Endocrinol., 286, 123, 10.1016/j.mce.2007.12.012 de Lecea, 2008, Cortistatin—functions in the central nervous system, Mol. Cell. Endocrinol., 286, 88, 10.1016/j.mce.2007.12.014 de Lecea, 2006, Cortistatin: not just another somatostatin analog, Nat. Clin. Pract. Endocrinol. Metab., 2, 356, 10.1038/ncpendmet0219 Deghenghi, 2001, Cortistatin but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland, J. Endocrinol. Invest., 24, RC1, 10.1007/BF03343800 Gonzalez-Rey, 2006, Neuropeptides as therapeutic approach to autoimmune diseases, Curr. Pharm. Des., 16, 3158, 10.2174/138161210793292465 Koch, 2010, Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis, Crit. Care, 14, R94, 10.1186/cc9029 Dalm, 2003, The role of somatostatin and somatostatin analogs in the pathophysiology of the human immune system, J. Endocrinol. Invest., 26, 94 Gonzalez-Rey, 2007, Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses, Ann. Rheum. Dis., 66, 582, 10.1136/ard.2006.062703 Souza-Moreira, 2013, Paradoxical effect of cortistatin treatment and its deficiency on experimental autoimmune encephalomyelitis, J. Immunol., 191, 2144, 10.4049/jimmunol.1300384 Dalm, 2003, Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system, J. Clin. Endocrinol. Metab., 88, 270, 10.1210/jc.2002-020950 Schmitz, 1982, The effect of solutions of varying branched-chain concentration on the plasma amino acid pattern and metabolism in intensive care patients, Clin. Nutr., 1, 147, 10.1016/0261-5614(82)90037-1 Chuang, 2006, Lessons from genetic disorders of branched-chain amino acid metabolism, J. Nutr., 243S, 10.1093/jn/136.1.243S Popov, 1992, Branchedchain a-ketoacid dehydrogenase kinase: molecular cloning, expression, and sequence similarity with histidine protein kinases, J. Biol. Chem., 267, 13127, 10.1016/S0021-9258(18)42179-5